$ALMS insider trading
Over the last 12 months, Alumis insiders reported 16 buys totaling $51.0M and 7 sales totaling $534K across SEC Form 4 filings.
- Bought · 12m
- $51.0M 16 events
- Sold · 12m
- $534K 7 events
- Events · 12m
- 23 Form 4 filings, grouped
- Insiders · 12m
- 10 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Schroer John R.Chief Financial Officer · O | ▼ Sale | 3,282 | $26.37 | $87K | -11.7% | — |
| Aug 3, 2026 | Pangali SanamChief Legal Officer · O | ▼ Sale | 1,364 | $26.37 | $36K | -12.3% | — |
| Aug 3, 2026 | Hardiman Roy C.Chief Business & Strategy Ofcr · O | ▼ Sale | 2,692 | $26.37 | $71K | -1.3% | — |
| Aug 3, 2026 | Goldstein David MChief Scientific Officer · O | ▼ Sale | 2,596 | $26.37 | $68K | -7.7% | — |
| Aug 3, 2026 | Drappa JornChief Medical Officer · O | ▼ Sale | 2,447 | $26.37 | $65K | -4.1% | — |
| Aug 3, 2026 | Bradley Mark ChristopherChief Development Officer · O | ▼ Sale | 2,572 | $26.37 | $68K | -5% | — |
| Jul 6, 2026 | Pangali SanamChief Legal Officer · O | ▼ Sale | 5,000 | $28 | $140K | -31% | — |
| Jan 9, 2026 | AKKARAJU SRINIVASD | ▲ Buy | 588,235 | $17 | $10.0M | +46.5% | indirect |
| Jan 8, 2026 | Foresite Labs, LLC10% | ▲ Buy | 411,764 | $17 | $7.0M | +16.5% | 2 tranches · indirect |
| Jan 8, 2026 | Foresite Capital Management VI LLC10% | ▲ Buy | 411,764 | $17 | $7.0M | +16.5% | 2 tranches · indirect |
| Jan 8, 2026 | Tananbaum James B.D·10% | ▲ Buy | 411,764 | $17 | $7.0M | +16.5% | 2 tranches · indirect |
| Dec 5, 2025 | AKKARAJU SRINIVASD | ▲ Buy | 186,377 | $9.84 | $1.8M | +17.3% | 3 tranches · indirect |
| Dec 4, 2025 | AKKARAJU SRINIVASD | ▲ Buy | 262,027 | $7.79 | $2.0M | +32.1% | 3 tranches · indirect |
| Dec 1, 2025 | AKKARAJU SRINIVASD | ▲ Buy | 173,589 | $7.55 | $1.3M | +27% | 3 tranches · indirect |
| Nov 21, 2025 | Foresite Capital Management VI LLC10% | ▲ Buy | 72,212 | $7.38 | $533K | +2.8% | indirect |
| Nov 21, 2025 | Tananbaum James B.D·10% | ▲ Buy | 72,212 | $7.38 | $533K | +2.8% | indirect |
| Nov 21, 2025 | Foresite Labs, LLC10% | ▲ Buy | 72,212 | $7.38 | $533K | +2.8% | indirect |
| Nov 20, 2025 | AKKARAJU SRINIVASD | ▲ Buy | 125,743 | $7.2 | $905K | +24.3% | indirect |
| Nov 19, 2025 | AKKARAJU SRINIVASD | ▲ Buy | 241,338 | $6.34 | $1.5M | +87.4% | 3 tranches · indirect |
| Nov 19, 2025 | Foresite Labs, LLC10% | ▲ Buy | 507,874 | $6.09 | $3.1M | +25% | 4 tranches · indirect |
| Nov 19, 2025 | Foresite Capital Management VI LLC10% | ▲ Buy | 507,874 | $6.09 | $3.1M | +25% | 4 tranches · indirect |
| Nov 19, 2025 | Tananbaum James B.D·10% | ▲ Buy | 507,874 | $6.09 | $3.1M | +25% | 4 tranches · indirect |
| Nov 13, 2025 | AKKARAJU SRINIVASD | ▲ Buy | 276,179 | $5.25 | $1.4M | — | indirect |
Every $ALMS filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Alumis filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ALMS feed.